
Work Here?
Xevant provides data analytics tailored for the pharmacy benefit management (PBM) sector to help PBMs, health plans, TPAs, and broker organizations control pharmacy spend. Its platform automates data analyses and monitors data in real time to surface hidden cost drivers, delivering actionable insights and alerts, while its services include system implementation, customization, training, and ongoing support. The product stands out by offering a turnkey, automated analytics solution combined with hands-on setup and client support, focused specifically on PBM data. The goal is to reduce overall pharmacy spend, improve patient outcomes, and boost client satisfaction and retention through data-driven optimization.
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$3.1M
Headquarters
Draper, Utah
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$3.1M
Meets
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Remote Work Options
Hybrid Work Options
Unlimited Paid Time Off
Parental Leave
Stock Options
Xevant named a 2025 Modern Healthcare Best in Business company for AI. Xevant, a leader in real-time pharmacy benefits intelligence, today announced it has been named a 2025 Modern Healthcare Best in Business company in the Artificial Intelligence (AI) category. The recognition honors healthcare suppliers and technology partners whose innovations delivered measurable impact across the healthcare ecosystem in 2025. U2Fx.com Nov 10, 2025 0 10 U2Fx.com Nov 30, 2025 0 12 U2Fx.com Oct 9, 2025 0 11 U2Fx.com Sep 15, 2025 0 96 U2Fx.com Oct 3, 2025 0 82 U2Fx.com Nov 26, 2025 0 80 U2Fx.com Oct 5, 2025 0 78
LEHI, Utah - (BUSINESS WIRE) - Xevant, a leader in real-time pharmacy benefits AI and analytics, today announced the launch of VerX (pronounced "Vair-ex"), a powerful new platform that redefines how pharmacy benefits are optimized, managed, and controlled.
LEHI, Utah, April 25, 2025 - (BUSINESS WIRE) - Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs).
Xevant introduces the all-new Biosimilar Dashboard, A Real-Time Analytics tool to accelerate biosimilar adoption and reduce unnecessary biologic Drug spend.
Xevant and Ivím Health are partnering to launch a corporate medical weight loss program called Ivím at Work.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$3.1M
Headquarters
Draper, Utah
Founded
2017
Find jobs on Simplify and start your career today